Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kathleen G. Lambert"'
Autor:
Patrick Ymele-Leki, Shugeng Cao, Jared Sharp, Kathleen G Lambert, Alexander J McAdam, Robert N Husson, Giselle Tamayo, Jon Clardy, Paula I Watnick
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31307 (2012)
Due to the inexorable invasion of our hospitals and communities by drug-resistant bacteria, there is a pressing need for novel antibacterial agents. Here we report the development of a sensitive and robust but low-tech and inexpensive high-throughput
Externí odkaz:
https://doaj.org/article/9843c48a4d704992ac1a54554b9a3aa7
Autor:
Patrick Ymele-Leki, Shugeng Cao, Jared Sharp, Kathleen G. Lambert, Alexander J. McAdam, Robert N. Husson, Giselle Tamayo, Jon Clardy, Paula I. Watnick
Publikováno v:
PLoS ONE, Vol 7, Iss 4 (2012)
Externí odkaz:
https://doaj.org/article/d768a54845f64fb9b52e7d8e0a4eaa68
Autor:
Meredith E. Hasenbein, Alexander J. McAdam, Kathleen G. Lambert, Sarah E. Cole, Andrew B. Onderdonk, John E. Warner
Publikováno v:
Journal of Clinical Microbiology. 42:1559-1563
Macrolide (including erythromycin and azithromycin) and lincosamide (including clindamycin) antibiotics are recommended for treatment of penicillin-allergic patients with Streptococcus pyogenes pharyngitis. Resistance to erythromycin in S. pyogenes c
Publikováno v:
Journal of Clinical Microbiology. 29:827-829
Routine monitoring of antibiotic resistance at Children's Hospital, Boston, detected a dramatic increase in the prevalence of imipenem-resistant strains of Pseudomonas aeruginosa. Further studies documented that false resistance to imipenem was due,
A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity
Autor:
Robert N. Husson, Paula I. Watnick, Jared D. Sharp, Giselle Tamayo, Kathleen G. Lambert, Patrick Ymele-Leki, Shugeng Cao, Jon Clardy, Alexander J. McAdam
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31307 (2012)
PLoS ONE
PLoS ONE
Due to the inexorable invasion of our hospitals and communities by drug-resistant bacteria, there is a pressing need for novel antibacterial agents. Here we report the development of a sensitive and robust but low-tech and inexpensive high-throughput
Publikováno v:
Pediatric Infectious Disease Journal; Aug2002, Vol. 21 Issue 8, p715-723, 9p